目的:观察吸入糖皮质激素对稳定期重度慢性阻塞性肺疾病(COPD)的疗效。方法:采用随机分组方法对本院2006~2007年门诊患者中筛选出符合入选标准的59例稳定期重度COPD患者进行随机分组,分别给予布地奈德/福莫特罗干粉吸入剂(治疗组)和福莫特罗干粉吸入剂(对照组)治疗半年,评估肺功能、呼吸困难程度、生活质量及慢性阻塞性肺疾病急性发作(AECOPD)等。疗效分析采用t检验或χ2检验。结果:59例患者均完成半年随访。结果显示:治疗组第1秒用力呼气、呼吸困难评分、6min步行距离和生活质量评分等指标均较对照组明显改善。且急性加重患者的门诊和住院人次较对照组少(P lt;0.05)。结论:吸入糖皮质激素治疗稳定期重度COPD有效。
Citation:
DUAN Lian.. The Therapeutic Effects of Inhaling Glucocorticoid to Cure Stable COPD Patients. West China Medical Journal, 2009, 24(6): 1435-1437. doi:
Copy
Copyright © the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved
1. |
CELLIB R, MACNEE W. ATS/ERS task force standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper[J]. Eur Respir J, 2004, 23(6): 923- 946.
|
2. |
中华医学会呼吸分会.慢性阻塞性肺疾病诊治指南[J]. 中华结核和呼吸病杂志,2002,25 (8):453-460.
|
3. |
何智辉,陈平.慢性阻塞性肺疾病患者体内白介素26和C反应蛋白质量浓度的变化及意义[J].中国实用内科杂志,2006,26 (13) 989-991.
|
4. |
CHRISTOPHER PN,NICHOLAS, EH. Beta Ardenocerter agonist block corticosteroid inhitition in eosinphils[J]. Am J Resp ir CritMed, 1998, 157: 184 --190.
|
5. |
PAUWELS R, LOFDAHL C, LAITINEN L, et al. Long term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking[J]. N Engl J Med, 1999, 340(25): 1948-1954.
|
- 1. CELLIB R, MACNEE W. ATS/ERS task force standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper[J]. Eur Respir J, 2004, 23(6): 923- 946.
- 2. 中华医学会呼吸分会.慢性阻塞性肺疾病诊治指南[J]. 中华结核和呼吸病杂志,2002,25 (8):453-460.
- 3. 何智辉,陈平.慢性阻塞性肺疾病患者体内白介素26和C反应蛋白质量浓度的变化及意义[J].中国实用内科杂志,2006,26 (13) 989-991.
- 4. CHRISTOPHER PN,NICHOLAS, EH. Beta Ardenocerter agonist block corticosteroid inhitition in eosinphils[J]. Am J Resp ir CritMed, 1998, 157: 184 --190.
- 5. PAUWELS R, LOFDAHL C, LAITINEN L, et al. Long term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking[J]. N Engl J Med, 1999, 340(25): 1948-1954.